FDA warns pregnant women of migraine drug risk

By: Associated Press Email
By: Associated Press Email
The Food and Drug Administration says the drugs, including Depakote and Depacon, should never be taken by pregnant women for the prevention of migraine headaches.

Depakote (Photo from the National Library of Medicine)

WASHINGTON (AP) -- U.S. health regulators are warning doctors and women of child-bearing age that half-a-dozen medications used to treat migraine headaches can decrease children's intelligence if taken while their mothers are pregnant.

The Food and Drug Administration says the drugs, including Depakote and Depacon, should never be taken by pregnant women for the prevention of migraine headaches.

The pills, which contain valproate sodium, already carry a warning about the risk of birth defects. But the FDA said it is adding new warnings to the drugs' labeling after a study showed they decreased IQ scores in children whose mothers took them while pregnant.

Depakote and similar drugs are also used to treat bipolar disorder and seizures. The FDA said pregnant women should only take the drugs for those uses as a last resort.


KKCO firmly believes in freedom of speech for all and we are happy to provide this forum for the community to share opinions and facts. We ask that commenters keep it clean, keep it truthful, stay on topic and be responsible. Comments left here do not necessarily represent the viewpoint of KKCO 11News.

powered by Disqus
KKCO NBC 11 News 2531 Blichmann Avenue Grand Junction, CO 81505 Station Phone: 970.243.1111 Business Fax: 970.243.1770 Newsroom Fax: 970.245.3793 News Tip & Contest Line: 970.255.8477
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 206322291 - nbc11news.com/a?a=206322291
Gray Television, Inc.